Macrophages and Tumor Necrosis Factor α in Toxic Epidermal Necrolysis

Archives of Dermatology

Volumn 130, Issue 5, 1994, Pages 605-608

  Paquet, Philippe ^a   Nikkels, Arjen ^a   Arrese, Jorge E ^a   Vanderkelen, Alain ^b   Piérard, Gerald E ^a  

^a Department of Dermatopathology University of Liège ^*  (United States)

^b QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMOXICILLIN; BLOOD CLOTTING FACTOR 13A; CD1 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CLINDAMYCIN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN; PHENYTOIN; PIPERACILLIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; EPIDERMAL NECROLYSIS, TOXIC; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGE; TUMOR NECROSIS FACTOR;

EID: 0028279347     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1994.01690050073012     Document Type: Article

References (13)

1. Merot Y, Gravallese E, Guillen F, Murphy G. Lymphocyte subsets and Langerhans’ cells in toxic epidermal necrolysis. Arch Dermatol. 1986; 122: 455-458.
2. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T-cell subsets in drug-induced toxic epidermal necrolysis. Arch Dermatol. 1991; 127: 851-855.
3. Heng M, Allen S. Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol. 1991; 25: 778-786.
4. Villada G, Roujeau JC, Clerici T, Bairgault I, Revuz J. Immunopathology of toxic epidermal necrolysis. Arch Dermatol. 1992; 128: 50-53.
5. Stern R, Chan HL. Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis. J Am Acad Dermatol. 1989; 21: 317-322.
6. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie. 1985; 40: 111-118.
7. Merot Y, Saurat JH. Clues to pathogenesis of toxic epidermal necrolysis. Int J Dermatol. 1985; 24: 165-168.
8. Roujeau JC, Dubertret LL, Moritz S, et al. Involvement of macrophages in the pathology of toxic epidermal necrosis. Br J Dermatol. 1985; 113: 425-430.
9. Headington JT, Cerio R. Dendritic cells and the dermis: 1990. Am J Dermatopathol. 1990; 12: 217-220.
10. Kock A, Urbanski A, Luger TA. mRNA expression and release of tumor necrosis factor-alpha by human epidermal cells. J Invest Dermatol. 1989; 92: 462.
11. Engelmann H, Holtmann H, Brakebusch C, et al. Antibodies to a soluble form of tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem. 1990; 265: 14497-14504.
12. Piguet P, Grau G, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med. 1991; 173: 673-679.
13. Luger TA. Epidermal cytokines. Acta Derm Venereol. 1989; 69(suppl 151): 61-76.